UNSPSC 85663005: Revision of nonautologous tissue substitute in upper tendon, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of nonautologous tissue substitute in upper tendon, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0LWX3KZ

UNSPSC 85663005 Revision of nonautologous tissue substitute in upper tendon, percutaneous approach is a Commodity code that shows no recent state and local procurement activity aligned with its nominal scope. The six most recent opportunities posted under this code—independent medical evaluations for disability retirement determinations (City of Phoenix), surgical and medical procedure carve-out benefits (City of Long Beach), occupational medical surveillance (Washington State Department of Transportation), emergency and specialty medical services for detained youth (Harris County Juvenile Probation Department), pharmacy benefit management (Collier County), and temporary health professional staffing (Santa Clara Health System)—are all administrative healthcare services, benefits management, and staffing services wholly unrelated to tissue-substitute revision procedures or any form of surgical intervention on upper tendons. The code appears to be a misclassification in one or more state and local procurement systems, suggesting vendors should verify actual commodity or service codes through direct inquiry to issuing offices rather than relying on posted code assignments.

State and local buyers using this code span county governments, city procurement offices, and regional health systems across Arizona, California, Florida, and Washington. None of the opportunities name dollar values, performance locations, or contract terms specific to tissue-substitute procedures or orthopedic surgery services. Without recent opportunities that match the code's stated scope, no meaningful market characterization by issuing-body concentration, geographic focus, or representative work is available.